Trial Profile
Phase I, Open Labeled, Dose Escalation trial in healthy male subjects to examine the Pharmacokinetics, Pharmacodynamics, and safety of single dose usage of F-627
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 27 Apr 2021
Price :
$35
*
At a glance
- Drugs Efbemalenograstim alfa (Primary)
- Indications Neutropenia
- Focus Adverse reactions
- 07 Jan 2015 New trial record